Trophic serves as a strategic partner for all aspects of communications for life science companies. We apply a deep understanding of both the science and business of drug development and the capital needed for success. Based on breadth and depth of experience, Trophic has become the go-to advisory for presenting corporate stories and scientific concepts. Current client portfolio ranges from biotech start-ups, listed biopharmas and small and large pharmaceutical companies.

TROPHIC TWITTER FEED

Follow us on Twitter to stay tuned on biotech news and the inner workings of the Trophic team

Happy to see our client @GtxMedical mentioned in a @forbes article highlighting the #FDA #BreakthroughDesignation status for its innovative Go-2 spinal implant device providing Targeted Epidural Spinal Stimulation (TESS) for people with #SpinalCordInjury:

Could A Spinal Implant Give Artificial Hands A Sense Of Touch?

Scientists based at the University of Pittsburgh have discovered a technique that they hope will allow people to ‘feel’ with prosthetic ha...

bit.ly

We dedicate July’s #BeanOfTheMonth to all #EssentialWorkers giving their all during the #pandemic, including #ServiceDogs. This @nytimes article highlights the importance of canine friends at a Children’s hospital. Bean wags her tail in approval: https://t.co/UZAjnoCH2o

With summer flowers in hand, fresh cake in the fridge & the boundless energy needed to support Team Bean, we are all wishing #Geburtstagskind @SophiaHergenhan a very happy birthday. 🌺🧁☀️

A very #HappyBirthday to our resident social media maven, @vw_fisher! We couldn't celebrate it together but we certainly Zang (Zoom sang) her wishes today. We hope you have a lovely day and Bean can't wait to partake in the celebratory festivities soon!
#AllesGute #TeamBean

Load More...